The HPV (Human Papillomavirus) vaccination protects against infections that cause cervical, anal, throat, and other cancers, as well as genital warts. It is most effective when administered before exposure to the virus, typically in preteens aged 11–12, though it can be given up to age 45. The vaccine stimulates the immune system to develop long-lasting protection against high-risk HPV strains. Safe and effective, it significantly reduces the risk of HPV-related diseases. Widespread vaccination not only protects individuals but also reduces the overall prevalence of HPV infections, contributing to community-level immunity and cancer prevention on a larger scale.
Myth #1: HPV vaccination increases risky sexual behaviour and promiscuity.
